rcca-header
Clinical Trials

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

Type of Cancer
Breast Oncology
Phase
Division (Location)
Hackensack, NJ
Study ID
NCT#
Brief Description
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.